Novavax, Inc. (NASDAQ:NVAX) Q4 2024 Earnings Call Transcript February 27, 2025
Novavax, Inc. misses on earnings expectations. Reported EPS is $-0.83 EPS, expectations were $-0.75.
Operator: Good morning and welcome to Novavax Fourth Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this...
